Neurology & Cognitive Health

Dementia

Dementia affects memory, thinking, behavior, and the ability to perform everyday activities. As the global aging population grows, the need for innovative dementia therapies and research continues to rise. CenExel partners with sponsors to advance clinical trials focused on improving cognitive function, slowing disease progression, and enhancing patient quality of life.

Studies Conducted
0 +
Trial Participants
0 +
Active Centers
0
Overview

Advancing Dementia Clinical Research

CenExel provides specialized expertise in dementia and neurodegenerative clinical research, supporting studies from early-stage evaluations through late-phase trials. Our experienced investigators and operational teams focus on patient-centered care, accurate cognitive assessments, and efficient study execution to help accelerate therapeutic innovation.

Improve Cognitive Research Outcomes

Our experienced neurology teams support high-quality dementia studies with precise data collection and patient-focused care.

Accelerate Study Performance

CenExel combines scientific expertise and operational excellence to improve enrollment timelines and study efficiency.
Conditions Covered

Dementia Conditions We Research

Our dementia research programs support a broad range of neurodegenerative and cognitive disorders across adult and aging populations.

  • Alzheimer’s Disease
  • Vascular Dementia
  • Lewy Body Dementia
  • Agitation Associated with Dementia
  • Mild Cognitive Impairment (MCI)
  • Parkinson’s Disease Dementia
  • Cognitive Decline Disorders
  • Pediatric Anxiety Disorders
Our Approach

Why Sponsors Choose CenExel for Dementia Research

CenExel delivers scientific expertise, operational consistency, and access to diverse patient populations for dementia and cognitive health studies.

01

Cognitive Assessment Expertise

We support complex neurological studies with validated cognitive testing and experienced research staff.

02

Specialized Recruitment Strategy

Our sites utilize targeted outreach strategies to identify and enroll qualified dementia study participants.

03

Diverse Patient Populations

Our nationwide network helps ensure broad demographic representation in dementia clinical trials.

04

High-Quality Study Execution

CenExel maintains strong operational performance across all study phases, helping sponsors achieve reliable results.

Phase Coverage

Supported Dementia Trial Phases

CenExel supports dementia and neurodegenerative studies from first-in-human research through Phase IV post-market trials.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our Dementia research network supports biomarker strategies, decentralized trial components, and patient-focused study execution for anxiety-related indications.

Let’s Advance Your Next Study

Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.

Explore Our Network

Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.

Our Blog